
Pharmaceuticals & Healthcare · NSE
Incorporated in 2003, Infinium Pharmachem Limited manufactures and supplies Iodine Derivatives, APIs, and iodination reaction-based bulk drugs. The company offers R&D services along with commercial-scale manufacturing and packaging for the pharmaceutical, agrochemical, nutraceutical, specialty chemicals, and other chemical industries. Its FDA-certified and GMP-compliant manufacturing facility in Gujarat spans 4,100 sq. m and is equipped to produce complex iodine derivatives. Infinium Pharmachem serves over 15 countries globally, offering more than 200 iodine derivatives and 7 APIs.
Price Band
₹135
Issue Size
₹25.26 Cr
Lot Size
1000 shares
GMP
Est. Listing
₹135
at current GMP
Subscribed
1.84x
overall
Open
31 Mar 2023
Close
5 Apr 2023
Allotment
11 Apr 2023
Refund
12 Apr 2023
Demat Credit
13 Apr 2023
Listing
17 Apr 2023
Designated Registrar: Bigshare Services Private Limited
Allotment Date
11 Apr 2023
Basis finalization
Refunds Initiate
12 Apr 2023
Mandate release
Demat Credit
13 Apr 2023
Shares in demat
Listing Debut
17 Apr 2023
Trading begins
Infinium Pharmachem Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Healthcare sector with an aggregate issue size of ₹25.26 Crores. The shares are offered at a price band of ₹135 to ₹135 per equity share on NSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2023-04-05, the basis of allotment is scheduled to be finalized on 2023-04-11. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.